相关实验视频

Updated: May 1, 2026

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Published on: December 28, 2014

半定量TAU PET方法用于布拉克分期:CenTauRz和STOC与视觉评估的一致性

Kaito Wachi¹, Tensho Yamao², Kenta Miwa^3,4

¹Department of Radiological Sciences, Graduate School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima-Shi, Fukushima, 960-8516, Japan.

Annals of nuclear medicine

|March 2, 2026

概括

半定量 PET成像方法,CenTauRz和STOC,显示与阿尔茨海默病 (AD) 的视觉布拉克分期有很强的一致性. 这些工具提高了解释病理的可靠性和客观性,有助于理解认知衰退.

科学领域:

神经成像是一种神经成像.
神经病理学神经病理学
阿尔茨海默氏症疾病研究研究

背景情况:

在阿尔茨海默氏症 (AD) 中的tau病理进展与认知能力下降相关.
图PET的视觉布拉克分期是标准的,但需要专家的解释.
需要客观可靠的PET量化方法.

研究的目的:

评估视觉布拉克分期和两个半定量陶PET方法之间的一致性:CenTauRz和简化时间-尾分类 (STOC).
评估这些方法在确定阿尔茨海默病中陶积累阶段的有用性.

主要方法:

利用F-flortaucipirPET和MRI数据来自ADNI3研究中的112名正常认知,103名MCI和48名AD参与者.
视觉布拉克分期由核医学医生进行.
CenTauRz的分数来自五个地区的标准化吸收值比率 (SUVRs);STOC阶段基于四个地区的SUVRs.
计算了与视觉布拉克阶段的对应性 (科恩的 κ) 和斯皮尔曼的相关性 (ρ).

主要成果:

CenTauRz表现出高精度 (0.84-0.90),一致性 (κ=0.61-0.77),以及与视觉布拉克阶段的相关性 (ρ=0.67-0.83).
STOC表现出强烈的同意,准确度为0.87, κ=0.71和 ρ=0.81.
CenTauRz有效地捕捉了区域的异性,而STOC提供了一个与Braak进展相一致的分阶段框架.

结论:

无论是Centaurz还是STOC都表现出强烈的同意,对tau PET的视觉评估布拉克阶段.
这些半定量方法可以作为有价值的补充工具,提高TAU PET解释的可靠性和客观性.
改善tau PET的解释可以帮助理解阿尔茨海默病的进展和认知衰退.

关键词:

18F-flortaucipir 的使用方法阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.布拉克的舞台制作这是一个CENTAURZZ.股票股票股票股票淘宝PET 宝贝宝贝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝宝

更多相关视频

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

相关概念视频

Kendall's Tau Test

Kendall's Tau Test

Kendall's tau test, also known as the Kendall rank coefficient test, is a nonparametric method for assessing association between two variables. This test is particularly useful for identifying significant correlations when the distributions of the sample and population are unknown. Developed in 1938 by the British statistician Sir Maurice George Kendall, the tau coefficient (denoted as τ) serves as a rank correlation coefficient, with values ranging from -1 to +1.
A τ value of +1...

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...